# A Study of Two Macitentan Pediatric Formulations in Healthy Adult Participants

> **NCT04963439** · PHASE1 · COMPLETED · sponsor: **Actelion** · enrollment: 16 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Macitentan

## Key facts

- **NCT ID:** NCT04963439
- **Lead sponsor:** Actelion
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-07-08
- **Primary completion:** 2021-09-12
- **Final completion:** 2021-10-05
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2025-03-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04963439

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04963439, "A Study of Two Macitentan Pediatric Formulations in Healthy Adult Participants". Retrieved via AI Analytics 2026-09-25 from https://api.ai-analytics.org/clinical/NCT04963439. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*